These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26553065)

  • 1. A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.
    Xi L; Schmidt JC; Zaug AJ; Ascarrunz DR; Cech TR
    Genome Biol; 2015 Nov; 16():231. PubMed ID: 26553065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated TERT promoter mutations abrogate telomerase silencing.
    Chiba K; Johnson JZ; Vogan JM; Wagner T; Boyle JM; Hockemeyer D
    Elife; 2015 Jul; 4():. PubMed ID: 26194807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutations in telomere biology.
    Heidenreich B; Kumar R
    Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells.
    Wen L; Zhao C; Song J; Ma L; Ruan J; Xia X; Chen YE; Zhang J; Ma PX; Xu J
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmable base editing of mutated TERT promoter inhibits brain tumour growth.
    Li X; Qian X; Wang B; Xia Y; Zheng Y; Du L; Xu D; Xing D; DePinho RA; Lu Z
    Nat Cell Biol; 2020 Mar; 22(3):282-288. PubMed ID: 32066906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence, functionality and abundance of the TERT promoter mutations.
    Rachakonda S; Hoheisel JD; Kumar R
    Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.
    Miki S; Koga T; Mckinney AM; Parisian AD; Tadokoro T; Vadla R; Marsala M; Hevner RF; Costello JF; Furnari F
    Neuro Oncol; 2022 Dec; 24(12):2063-2075. PubMed ID: 35325218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
    Min J; Shay JW
    Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells.
    Ravindranathan A; Cimini B; Diolaiti ME; Stohr BA
    PLoS One; 2018; 13(12):e0206525. PubMed ID: 30517099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting oncogenic TERT promoter variants by allele-specific epigenome editing.
    Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
    Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 4-Base-Pair Core-Enclosing Helix in Telomerase RNA Is Essential for Activity and for Binding to the Telomerase Reverse Transcriptase Catalytic Protein Subunit.
    Mefford MA; Hass EP; Zappulla DC
    Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33046533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic features in regulation of telomeres and telomerase in stem cells.
    Dogan F; Forsyth NR
    Emerg Top Life Sci; 2021 Oct; 5(4):497-505. PubMed ID: 34486664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9.
    Kühn R; Chu VT
    Genome Biol; 2015 Nov; 16():244. PubMed ID: 26553112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P. berghei telomerase subunit TERT is essential for parasite survival.
    Religa AA; Ramesar J; Janse CJ; Scherf A; Waters AP
    PLoS One; 2014; 9(9):e108930. PubMed ID: 25275500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
    Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
    PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.
    Aquilanti E; Kageler L; Watson J; Baird DM; Jones RE; Hodges M; Szegletes ZM; Doench JG; Strathdee CA; Figueroa JRMF; Ligon KL; Beck M; Wen PY; Meyerson M
    Neuro Oncol; 2023 Jul; 25(7):1275-1285. PubMed ID: 36694348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.
    Porika M; Tippani R; Saretzki GC
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.